Clinical trials
Pneumonia clinical trials
Below are recruiting pneumonia clinical trials, each written for real people, not researchers. We’re tracking 243 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07255742Recruiting
Lactoferrin to prevent pneumonia in babies on breathing machines
This study tests whether giving lactoferrin (a protein found in breast milk and other body fluids) to newborns on a ventilator (breathing machine) can prevent a lung infection called ventilator-associated pneumonia.
TantaAges birth–3 months - NCT05979545RecruitingPhase 4
Early treatment with ceftazidime-avibactam for serious infections
This study tests an antibiotic called ceftazidime-avibactam for people with serious infections like bloodstream infections or pneumonia that started in the hospital or from a breathing machine. It aims to start treatment quickly after identifying the bacteria.
Kuala LumpurAges Any age - NCT07848165Recruiting
Probiotics to prevent pneumonia in children on breathing machines
This trial tests whether giving probiotics (good bacteria) can help prevent pneumonia in children who are on a breathing machine in the intensive care unit. If your child is on a ventilator, these friendly bacteria might help keep their lungs healthy.
Tanta, Al GharbiaAges 1 month–18 years - NCT02735707RecruitingPhase 3
Adaptive trial for severe pneumonia care in intensive care
This study tests ways to improve treatment for adults with severe pneumonia that lands them in the ICU, adjusting the plan as results come in. It may help your care team find better treatments for lung infection and breathing/heart support needs.
Jacksonville, FloridaAges 18 years+ - NCT06511583Recruiting
Bronchoscopy for aspiration pneumonia in the ER
This trial tests if using a thin, flexible scope (bronchoscopy) to suck out fluid and debris from the lungs helps adults with aspiration pneumonia in the emergency room. It is for those who need help clearing their airways due to swallowing problems or pneumonia on imaging.
Florence, Tuscany/ItalyAges 18 years+ - NCT07745491Recruiting
AI tool to predict pneumonia after heart surgery
This study uses artificial intelligence to help predict if patients might develop pneumonia after heart or blood vessel surgery. It aims to find warning signs early so doctors can act sooner.
TomskAges 18 years+ - NCT06499233RecruitingPhase 4
Study on preventing pneumocystis pneumonia in autoimmune disease
This trial tests whether a preventive treatment can stop pneumocystis pneumonia (a lung infection) in people with autoimmune inflammatory rheumatic diseases who are taking steroids or other immune-suppressing medicines. It aims to find the safest and most effective way to protect you from this serious infection.
Wuhan, HubeiAges 18 years+ - NCT06657898Recruiting
Complicated pneumonia in children in Southeast Europe
This study looks back at children who had a serious type of pneumonia (complicated pneumonia) between 2014 and 2024 in Southeast Europe. It aims to learn more about these infections to help improve care for kids in the future.
BelgradeAges 1 month–18 years - NCT07667582Recruiting
Pneumonia in ventilated patients
This study looks at patients who got pneumonia while in the hospital and needed a breathing tube. It helps doctors understand what causes it and how it affects recovery.
Asyut, Asyut GovernorateAges 18–100 - NCT06691399Recruiting
Mouth care to prevent pneumonia in ICU COPD patients
This study tests whether a special mouth-care routine can help prevent pneumonia (a serious lung infection) in people with COPD who are in the ICU and need breathing support. If you are in the ICU with a COPD flare-up and are using a noninvasive breathing mask or high-flow oxygen, you may be able to join.
AsyutAges 18 years+ - NCT06691321Recruiting
Caspofungin for Pneumocystis Pneumonia in HIV patients
This trial tests caspofungin, a medicine, for treating Pneumocystis pneumonia (PCP) in people living with HIV. It aims to see if it works better than standard treatments.
Mexico City, TlalpanAges 18–60 - NCT07615010RecruitingPhase 2
agenT-797 Plus Standard Care for Severe Pneumonia With Respiratory Failure
This trial tests whether adding an experimental drug called agenT-797 to standard pneumonia treatment helps patients in the ICU who have severe pneumonia and serious difficulty breathing (acute hypoxemic respiratory failure). The drug is designed to help the immune system fight severe infection.
San Francisco, CaliforniaAges 18 years+ - NCT07604103RecruitingPhase 3
Heart Attack and Pneumonia Recovery Study With Vaccination
This study looks at blood markers (special proteins) in patients who have had both a heart attack and pneumonia, to see how vaccination affects recovery. The goal is to understand whether flu and pneumonia vaccines are safe and helpful for people recovering from these two serious conditions together.
Malang, East JavaAges 18–65 - NCT06114888Recruiting
New diagnostic tests for children hospitalized with pneumonia
This study tests new ways to diagnose pneumonia in children who are hospitalized. It aims to find the best methods to quickly identify the cause of pneumonia, so your child can get the right treatment sooner.
Hamilton, OntarioAges 6 months–18 years - NCT07552116Recruiting
Low-intensity laser therapy for pneumonia in children with Down syndrome
This trial tests whether a special low-intensity laser treatment can help boost the immune system and fight pneumonia in children with Down syndrome. Researchers want to see if this approach might help children recover better from their first pneumonia infection.
CairoAges 3–5 - NCT07551258Recruiting
Immune System Changes and Lung Infection in Critically Ill Older Adults
This study looks at how the immune system changes in older patients on breathing machines in the ICU, and whether these changes affect the risk of developing pneumonia. Understanding this may help doctors better protect critically ill patients from infection.
L'Hospitalet de Llobregat, BarcelonaAges 18 years+ - NCT06693362RecruitingPhase 1
Stem cell therapy for severe viral pneumonia
This trial tests whether injecting stem cells from the womb's blood supply can help treat severe viral pneumonia. It aims to improve recovery for people who are very sick and need hospital care.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT07512596RecruitingPhase 2
Study of a new antibiotic for hospital pneumonia from resistant bacteria
This trial tests a drug called Polymyxin E2 Methanesulfonate for a serious lung infection that patients can get in the hospital, caused by bacteria that don't respond to common antibiotics. It may be an option for people on ventilators or recently hospitalized with pneumonia that standard drugs can't treat.
Bengbu, AnhuiAges 18 years+ - NCT07492771RecruitingPhase 1
Study of MP101 for adults with Pseudomonas pneumonia
This trial tests an experimental treatment called MP101 for adults with pneumonia caused by the bacteria Pseudomonas aeruginosa (PA). It aims to help patients whose infection is not responding to current antibiotics.
Seoul, Seodaemun-guAges 19 years+ - NCT07476274Recruiting
Study of pneumonia after heart bypass surgery
This trial looks at pneumonia that happens in the hospital after coronary artery bypass surgery. It aims to understand who is at risk and how to better prevent or treat it.
Tomsk, Tomsk OblastAges 18 years+ - NCT07463443Recruiting
Chatbot support for caregivers of elderly pneumonia patients
This study tests a chatbot that gives you information and tips while you care for an elderly loved one with pneumonia. Participating may help you feel more confident and improve your caregiving skills.
Taipei, TaiwanAges 18 years+ - NCT07436780Recruiting
Immune cells in the lungs of ventilated patients
This study looks at immune cells in the lungs of people on breathing machines. It aims to understand how these cells change in patients who develop pneumonia while on the ventilator.
LimogesAges 18 years+ - NCT07442656Recruiting
Frailty and outcomes in older adults with pneumonia
This study looks at how frailty (overall weakness and decline) affects recovery in older adults who come to the emergency room with pneumonia. The goal is to understand what outcomes patients can expect based on their frailty level.
Izmir, BornovaAges 65 years+ - NCT04647630Recruiting
Check which pneumococcus types cause pneumonia
This trial looks at which “pneumococcus” (a common germ) types are causing pneumonia in people admitted to the hospital. It uses a urine test kit to see how often different pneumococcal types are involved, which may help future treatment choices.
ShatinAges 18 years+
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pneumonia?
- Yes. Clin2 currently lists 243 recruiting pneumonia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pneumonia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pneumonia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.